Prasad Yeshwant Deshmukh
M.G.M. Medical College
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Prasad Yeshwant Deshmukh.
International journal of reproduction, contraception, obstetrics and gynecology | 2017
Michelle N. Fonseca; Prasad Yeshwant Deshmukh; Deepali Kharat
1 Dr Michelle Fonseca. Dr Deepali Kharat, Dr Prasad Deshmukh DMPA: Acceptance and compliance in a tertiary care hospital in Mumbai India IJRCOG September 2017, Vol 6, Issue 9; 3879-3881 2 Dr Michelle Fonseca. Dr Deepali Kharat, Dr Prasad Deshmukh Progesterone only Pills: an effective contraception option for lactating women IJRCOG October 2017, Vol 6, Issue 10; 4399-4401 3 Dr Michelle Fonseca. Dr Deepali Kharat, Dr Prasad Deshmukh A randomized single blind control study to assess the effect of intrapartum amnioinfusion on maternal caesarean section rate and foetal outcome in a tertiary care centre IJRCOG October 2017, Vol 6, Issue 10; 43474350
International journal of reproduction, contraception, obstetrics and gynecology | 2015
Ankita Pandey; Sarmila Kundu; Prasad Yeshwant Deshmukh
Background: Second trimester abortions generally account for less number of patients as compared to first trimester abortions as patients generally come earlier as soon as pregnancy is recognized but now days due to advent of USG many cases of fetal anomaly are detected earlier accounting for increasing number of cases of second trimester. Methods: Present study was conducted among patients with pregnancy between 13-20 weeks of period of gestation (to be randomly assigned) after getting approval from institutional ethics committee and informed consent from the patient. Participants were randomly allocated to receive 400 μg of misoprostol either sublingually or intravaginally every six hours for a maximum of 5 doses. The blood pressure, pulse rate & temperature and side effects monitored every 3 hrs. If women in either group failed to abort after 48 hours of initiation of treatment termed as failure. In cases of failure they were given additional doses of sublingual misoprostol till abortion occurred. Primary outcome variable compared was success rate at 48 hours. Secondary outcome variables compared were bleeding patterns, completeness of abortion, induction abortion interval and any side effects. Results: It has been found that vaginal misoprostol 400 micro gm achieved a success rate to 100% in 48 hours, while the success rate was 93.33% with the sublingual route. (P = 0.4915, NS). Conclusions: Thus from our limited study population, we conclude that there is no significant difference in efficacy and complications between the two routes, although a larger cohort is required to get more dependable result.
The Journal of medical research | 2014
Shaifali Patil; Nimain Mohanty; Nidhi Kurkal; Rama Borse; Prasad Yeshwant Deshmukh
International journal of reproduction, contraception, obstetrics and gynecology | 2017
Mansi Shukla; Mallika Fonseca; Prasad Yeshwant Deshmukh
International journal of reproduction, contraception, obstetrics and gynecology | 2017
Mahesweta Guru; Prasad Yeshwant Deshmukh
International journal of reproduction, contraception, obstetrics and gynecology | 2017
Michelle N. Fonseca; Prasad Yeshwant Deshmukh; Deepali Kharat
International journal of reproduction, contraception, obstetrics and gynecology | 2015
Prasad Yeshwant Deshmukh; B. G. Boricha; Ankita Pandey
International journal of reproduction, contraception, obstetrics and gynecology | 2015
Ankita Pandey; Prasad Yeshwant Deshmukh; Madhuri Mehendale; Y. S. Nandanwar
International journal of reproduction, contraception, obstetrics and gynecology | 2015
Ankita Pandey; Prasad Yeshwant Deshmukh; Balaji Jadhav; Y. S. Nandanwar
International journal of reproduction, contraception, obstetrics and gynecology | 2014
Prasad Yeshwant Deshmukh; Shaifali Patil; B. G. Boricha